Related Experiment Videos
Potential for vaccination against infections caused by Staphylococcus aureus
1Microbiology Department, Moyne Institute, Trinity College, Dublin, Ireland.
Vaccine
|April 1, 1991
Summary
Surface components of Staphylococcus aureus, including polysaccharides and proteins, are key targets for developing new vaccines. These components contribute to bacterial virulence and can be used to combat infections like mastitis and nosocomial diseases.
Area of Science:
- Microbiology
- Immunology
- Vaccine Development
Background:
- Staphylococcus aureus (S. aureus) causes significant human and animal diseases, including mastitis and nosocomial infections.
- Surface polysaccharides and proteins of S. aureus play crucial roles in bacterial virulence, immune evasion, and host cell adherence.
Purpose of the Study:
- To review the properties of S. aureus surface polysaccharides and proteins.
- To discuss their contribution to virulence.
- To explore their potential as components for novel subunit vaccines against staphylococcal diseases.
Main Methods:
- Characterization of surface polysaccharides and proteins from S. aureus isolates.
- Review of existing literature on S. aureus virulence factors and vaccine development.
Main Results:
- S. aureus often produces a polysaccharide capsule that impairs phagocytosis.
- Surface proteins facilitate binding of host proteins and adherence to host tissues.
- Immunization with polysaccharide has induced protective immunity in animal models.
Conclusions:
- S. aureus surface polysaccharides and proteins are promising candidates for subunit vaccines.
- Vaccines targeting these components could combat bovine mastitis and human nosocomial infections.